2026-03-30 21:35:24
DarioHealth Corp. Enters $20 Million Sales Agreement for Common Stock Offering
Expected Stock impact: Slightly Positive
On March 30, 2026, DarioHealth Corp., a Delaware corporation, announced that it has entered into a sales agreement with A.G.P./Alliance Global Partners. This agreement allows the company to issue and sell up to $20 million of its common stock through an 'at the market offering' program. The sales will be conducted by A.G.P. acting as the sales agent or principal, and the company retains the right to suspend or terminate the offering at any time. The proceeds from this offering are intended for various corporate purposes, including commercial activities, research and development, and the repayment of existing debt. The sales agreement stipulates a commission of 3% on the gross proceeds from the sale of shares, along with reimbursement of certain expenses incurred by the agent. This move is seen as a strategic effort to bolster the company's liquidity and support its operational initiatives. The shares will be issued under the company's effective shelf registration statement on Form S-3, which was declared effective by the SEC on March 27, 2026. This offering is expected to provide DarioHealth with the necessary capital to enhance its market position and drive growth in its business operations.
